logo

For the Inventor, By the Inventor

New York, NY, United States of America

Samuel Clark

This inventor holds 11 USPTO granted patents and 27 published patent applications. Top assignees: Terran Biosciences, Inc., Columbia University, Research Foundation for Mental Hygiene, Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samuel Clark. Retrieved from https://idiyas.com/inventor/samuel-clark-jq9nxeua

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 100.0

Average Co-Inventor Count = 1.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal10 out of 12 
 
Terran Biosciences, Inc.
 patents
silverMedal1 out of 2,560 
 
Columbia University
 patents
bronzeMedal1 out of 45 
 
Research Foundation for Mental Hygiene, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2023-2026

Loading Chart...
11 patents (USPTO):Explore Patents
1. 12612364 - Salts and solid forms of 4-hydroxy--diisopropyltryptamine hemi-glutarate and hemi-succinate (2026-04-28),
2. 12577222 - Phenethylamine compounds salts, polymorphic forms and methods of use thereof (2026-03-17),
3. 12435036 - Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-n,n-dimethylpropan-2-amine (2025-10-07),
4. 12319652 - Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amine (2025-06-03),
5. 12269818 - Analogs of xanomeline (2025-04-08),
6. 12234216 - Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof (2025-02-25),
7. 12079960 - Systems, devices, and methods for harmonization of imaging datasets including biomarkers (2024-09-03),
8. 11958821 - Phenethylamine compounds salts, polymorphic forms and methods of use thereof (2024-04-16),
9. 11945832 - Psilocybin and O-acetylpsilocin, salts and solid state forms thereof (2024-04-02),
10. 11905295 - Solid forms of tabernanthalog monofumarate salt for treating neurological disorders and/or psychiatric disorders (2024-02-20),
11. 11851452 - Psilocybin and O-acetylpsilocin, salts and solid state forms thereof (2023-12-26),

Title: Samuel Clark: Innovator in Neurological Treatments

Introduction

Samuel Clark is a notable inventor based in New York, NY, who has made significant contributions to the field of neurological and psychiatric treatments. With a total of nine patents to his name, he has focused on developing innovative solutions that address critical health issues.

Latest Patents

Among his latest patents are the salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amine. These patents are directed towards methods of treating neurological disorders and psychiatric disorders in subjects in need. His work in this area highlights the potential for new therapeutic approaches to complex health challenges.

Career Highlights

Samuel Clark has worked with prominent organizations such as Terran Biosciences, Inc. and Columbia University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Matthew Duncton and Kenneth Wengler. Their combined expertise has fostered an environment of innovation and discovery in the projects they have undertaken together.

Conclusion

Samuel Clark's contributions to the field of neurological and psychiatric treatments through his patents and collaborations underscore his role as a significant inventor. His work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…